Marco Metra to Relaxin
This is a "connection" page, showing publications Marco Metra has written about Relaxin.
Connection Strength
2.931
-
Effects of Serelaxin in Patients with Acute Heart Failure. N Engl J Med. 2019 08 22; 381(8):716-726.
Score: 0.803
-
Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF. Int J Cardiol. 2018 02 15; 253:91-96.
Score: 0.723
-
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. Eur J Heart Fail. 2017 06; 19(6):800-809.
Score: 0.684
-
Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial. Am Heart J. 2017 Aug; 190:113-122.
Score: 0.172
-
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial. Am Heart J. 2017 May; 187:62-69.
Score: 0.169
-
Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol. 2017 Jun; 106(6):444-456.
Score: 0.168
-
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Eur J Heart Fail. 2017 08; 19(8):1001-1010.
Score: 0.168
-
Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients. Clin Exp Hypertens. 2018; 40(7):637-643.
Score: 0.045